Clickable Granular Hydrogel Scaffolds for Delivery of Neural Progenitor Cells to Sites of Spinal Cord Injury
Advanced Healthcare Materials · 2024-10 · 13 (25)
DOI: 10.1002/adhm.202303912 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 24.03.2024. Verfasst von Thomas J Tigner und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Texas A&M University, College Station, TX, 77843-3120, USA. Hauptthemen laut MEDLINE: Spinal Cord Injuries, Neural Stem Cells, Tissue Scaffolds, Polyethylene Glycols. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NINDS NIH HHS, NCI NIH HHS, NIH HHS.
Abstract (Originalsprache)
Spinal cord injury (SCI) is a serious condition with limited treatment options. Neural progenitor cell (NPC) transplantation is a promising treatment option, and the identification of novel biomaterial scaffolds that support NPC engraftment and therapeutic activity is a top research priority. The objective of this study is to evaluate in situ assembled poly (ethylene glycol) (PEG)‐based granular hydrogels for NPC delivery in a murine model of SCI. Microgel precursors are synthesized by using thiol‐norbornene click chemistry to react four‐armed PEG‐amide‐norbornene with enzymatically degradable and cell adhesive peptides. Unreacted norbornene groups are utilized for in situ assembly into scaffolds using a PEG‐di‐tetrazine linker. The granular hydrogel scaffolds exhibit good biocompatibility and do not adversely affect the inflammatory response after SCI. Moreover, when used to deliver NPCs, the granular hydrogel scaffolds supported NPC engraftment, do not adversely affect the immune response to the NPC grafts, and successfully support graft differentiation toward neuronal or astrocytic lineages as well as axonal extension into the host tissue. Collectively, these data establish PEG‐based granular hydrogel scaffolds as a suitable biomaterial platform for NPC delivery and justify further testing, particularly in the context of more severe SCI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, Texas A&M University, College Station, TX, 77843-3120, USA.
- Department of Biology, Texas A&M University, College Station, TX, 77843-3258, USA.
- Texas A&M Institute for Neuroscience, Texas A&M University, College Station, TX, 77843-3474, USA.
- Department of Materials Science and Engineering, Texas A&M University, College Station, TX, 77843-3003, USA.
ORCID-Profile: Daniel L Alge
Förderung
- NINDS NIH HHS
- NCI NIH HHS
- NIH HHS
- National Science Foundation's Graduate Research Fellowship Program
- Congressionally Directed Medical Research Programs
- Craig H. Neilsen Foundation
- National Institutes of Health
- National Institute of Neurological Disorders and Stroke
Zitieren
APA
Tigner, T. J., Dampf, G., Tucker, A., Huang, Y. C., Jagrit, V., Clevenger, A. J., Mohapatra, A., Raghavan, S. A., Dulin, J. N., & Alge, D. L. (2024). Clickable Granular Hydrogel Scaffolds for Delivery of Neural Progenitor Cells to Sites of Spinal Cord Injury. Advanced Healthcare Materials, 13(25). https://doi.org/10.1002/adhm.202303912
Vancouver
Tigner TJ, Dampf G, Tucker A, Huang YC, Jagrit V, Clevenger AJ, et al. Clickable Granular Hydrogel Scaffolds for Delivery of Neural Progenitor Cells to Sites of Spinal Cord Injury. Advanced Healthcare Materials. 2024;13(25). doi:10.1002/adhm.202303912
BibTeX
@article{Tigner2024,
author = {Tigner, Thomas J and Dampf, Gabrielle and Tucker, Ashley and Huang, Yu-Chi and Jagrit, Vipin and Clevenger, Abigail J and Mohapatra, Arpita and Raghavan, Shreya A and Dulin, Jennifer N and Alge, Daniel L},
title = {Clickable Granular Hydrogel Scaffolds for Delivery of Neural Progenitor Cells to Sites of Spinal Cord Injury},
journal = {Advanced Healthcare Materials},
year = {2024},
volume = {13},
number = {25},
doi = {10.1002/adhm.202303912}
}
EUVIMED